BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6845404)

  • 1. Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma.
    Smith MT; Livingstone I; Hooper WD; Eadie MJ; Triggs EJ
    Ther Drug Monit; 1983; 5(1):87-93. PubMed ID: 6845404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of propranolol in the human maternal-placental-foetal unit.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 24(6):727-32. PubMed ID: 6884410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol in pregnancy three year prospective study.
    Livingstone I; Craswell PW; Bevan EB; Smith MT; Eadie MJ
    Clin Exp Hypertens B; 1983; 2(2):341-50. PubMed ID: 6872291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
    Pritchard F; Schneck D; Hayes A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):279-86. PubMed ID: 461953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of diltiazem versus cimetidine on propranolol metabolism.
    Tateishi T; Ohashi K; Fujimura A; Ebihara A
    J Clin Pharmacol; 1992 Dec; 32(12):1099-104. PubMed ID: 1487547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.
    Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
    J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.
    Lo MW; Pond SM; Effeney DJ; Silber BM; Riegelman S; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):401-12. PubMed ID: 6527232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol metabolism in normal subjects: association with sex steroid hormones.
    Walle T; Walle K; Mathur RS; Palesch YY; Conradi EC
    Clin Pharmacol Ther; 1994 Aug; 56(2):127-32. PubMed ID: 8062488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Excretion of propranolol in human breast milk.
    Karlberg B; Lundberg D; Aberg H
    Acta Pharmacol Toxicol (Copenh); 1974 Mar; 34(3):222-4. PubMed ID: 4406326
    [No Abstract]   [Full Text] [Related]  

  • 10. Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
    Dan M; Weidekamm E; Sagiv R; Portmann R; Zakut H
    Antimicrob Agents Chemother; 1993 Feb; 37(2):293-6. PubMed ID: 8452360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of propranolol and its major metabolite, naphthoxylactic acid, in human plasma by high performance liquid chromatography.
    Takei H; Ogata H; Ejima A
    Chem Pharm Bull (Tokyo); 1983 Apr; 31(4):1392-4. PubMed ID: 6627514
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic propranolol administration during pregnancy. Maternal pharmacokinetics.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 25(4):481-90. PubMed ID: 6653642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of alpha-naphthoxylactic acid, a major metabolite of propranolol, in plasma by high-performance liquid chromatography.
    Harrison PM; Tonkin AM; Dixon ST; McLean AJ
    J Chromatogr; 1986 Jan; 374(1):223-5. PubMed ID: 3949934
    [No Abstract]   [Full Text] [Related]  

  • 14. [Elimination of nalbuphine in human milk].
    Wischnik A; Wetzelsberger N; Lücker PW
    Arzneimittelforschung; 1988 Oct; 38(10):1496-8. PubMed ID: 3196391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of naphthoxylactic acid, a major metabolite of propranolol in plasma in man.
    Easterling DE; Walle T; Conradi EC; Gaffney TE
    J Chromatogr; 1979 Mar; 162(3):439-45. PubMed ID: 528611
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-hypertensive therapy with propranolol during pregnancy and lactation.
    Taylor EA; Turner P
    Postgrad Med J; 1981 Jul; 57(669):427-30. PubMed ID: 7312737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy.
    Thorley KJ; McAinsh J
    Biopharm Drug Dispos; 1983; 4(3):299-301. PubMed ID: 6626704
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine.
    Garceau Y; Davis I; Hasegawa J
    J Pharm Sci; 1978 Jun; 67(6):826-31. PubMed ID: 660467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat.
    Fleishaker JC; Desai N; McNamara PJ
    J Pharm Sci; 1987 Mar; 76(3):189-93. PubMed ID: 3585733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of chloroquine and desethylchloroquine in human milk.
    Ogunbona FA; Onyeji CO; Bolaji OO; Torimiro SE
    Br J Clin Pharmacol; 1987 Apr; 23(4):473-6. PubMed ID: 3580253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.